Who invested in AnTolRx?
AnTolRx's investors include Pfizer.
United States · Series A startup
One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$4.0Mraised across 1 round since 2016, from 1 source
AnTolRx's investors include Pfizer.
AnTolRx has raised $4.0M across 1 round since 2016.
AnTolRx's most recent round was a Series A of $4.0M in Sept 2016.
Its most recent round, $4.0M in Sept 2016, is also its largest on record.
AnTolRx's first round on record, in Sept 2016, was backed by Pfizer.
AnTolRx's latest named round is a Series A, in Sept 2016.
AnTolRx is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.